Urinary Elimination of Coproporphyrins Is Dependent onABCC2 Polymorphisms and Represents a Potential Biomarker of MRP2 Activity in Humans
Open Access
- 1 January 2011
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 498757
Abstract
MRP2 encoded by ABCC2 gene is involved in the secretion of numerous drugs and endogenous substrates. Patients with Dubin‐Johnson syndrome due to mutation in ABCC2 gene have elevated urinary coproporphyrin ratio (UCP I/(I + III)). Here we investigated whether this ratio could serve as a biomarker of MRP2 function. Phenotype‐genotype relationships were studied in 74 healthy subjects by measuring individual UCP I/(I + III) ratio obtained on 24‐hour urine and by analyzing five common SNPs in ABCC2 gene. The UCP I/(I + III) ratio varied from 14.7% to 46.0% in our population. Subjects with 3972TT genotype had a higher ratio (P = .04) than those carrying the C allele. This higher UCP I/(I + III) ratio was correlated with a higher level of isomer I excretion. This study provides a proof of concept that UCP I/(I + III) ratio can be used as a biomarker of MRP2 function in clinical studies as it provides quantitative information about the in vivo activity of MRP2 in a given patient.Keywords
This publication has 34 references indexed in Scilit:
- A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate SpecificityScience, 2007
- Irinotecan-induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter ProteinClinical Pharmacology & Therapeutics, 2007
- Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary StructureScience, 2006
- Influence of Drug Transporter Polymorphisms on Pravastatin Pharmacokinetics in HumansPharmaceutical Research, 2006
- Association betweenABCC2Gene Haplotypes and Tenofovir‐Induced Proximal TubulopathyThe Journal of Infectious Diseases, 2006
- High-dose methotrexate in pediatric acute lymphoblastic leukemia: Impact of ABCC2 polymorphisms on plasma concentrationsClinical Pharmacology & Therapeutics, 2006
- Multidrug Resistance Protein 2 Genetic Polymorphisms Influence Mycophenolic Acid Exposure in Renal Allograft RecipientsTransplantation, 2006
- MRP2 and 3 in health and diseaseCancer Letters, 2006
- DISPOSITION OF ORAL AND INTRAVENOUS PRAVASTATIN IN MRP2-DEFICIENT TR– RATSDrug Metabolism and Disposition, 2005
- VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATIONDrug Metabolism and Disposition, 2005